Adam Eshborn, a 51-year-old father of two from Catterall, joined the EUROPAC cancer research study due to his history of pancreatitis and the hereditary nature of the condition. He hopes his participation will contribute to earlier detection and improved survival rates for pancreatic cancer, a disease with one of the lowest survival rates among all cancers.
As a child, Adam Eshborn suffered with symptoms of pancreatitis and struggled with chronic pain and digestive symptoms from the age of 10.
51-year-old Adam said: “I decided to take part in the trial just before I was due to be married. We knew we wanted to start a family, so I started to take my health more seriously. One in 10 cases of pancreatic cancers can be linked to hereditary conditions such as PRSS1 gene mutations which means the pancreas is unable to break down a certain enzyme, damaging the pancreas and can eventually lead to cancer. The trial for Adam, who is a keen runner and keeps as fit as possible, means he attends a screening each year which monitors his condition and the general health of his pancreas.
Recommended the procedure by Professor Christopher Halloran, Honorary Consultant Pancreatic Surgeon at Royal Liverpool University Hospital and Professor of Pancreatic Surgery at the University of Liverpool, Adam underwent a total pancreatectomy at the Royal Liverpool University Hospital, which confirmed a significant pre-cancerous area.
Four years on from this and Adam is still getting used to life without a pancreas, including the side effects of the condition and the treatment. His two children have been tested for the PRSS1 condition when they were toddlers, with his 13-year-old son discovered to have the same condition as Adam. Professor Halloran said: “EUROPAC along with its partners, NHS England, Pancreatic Cancer UK, Cheshire and Merseyside Cancer Alliance, the University of Liverpool and the Royal Liverpool University Hospital, have developed systems with national reach to find treatable pancreatic lesions before they develop into cancer.”
Pancreatic Cancer EUROPAC Cancer Research Hereditary Conditions Early Detection
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Viktor Gyokeres joins exclusive three-man club with Lionel Messi with heroics against Man City...Watch Sporting Lisbon fans emulate Viktor Gyökeres's batman celebration.
Read more »
Binghamton University joins groundbreaking $42.8 million inflammatory disease treatment projectBinghamton University will play a key role in a federal grant of up to $42.8 million to develop an implantable device that acts as a living pharmacy to treat inflammatory diseases.
Read more »
Funding boost for Manchester lung cancer research offers hope to families like Rebecca'sFunding will support groundbreaking research to improve the survival rates of lung cancer patients.
Read more »
'I would have developed cancer if it wasn't for groundbreaking research'A Preston dad has spoken about a trial that saved his life
Read more »
Using a molecular testing technology for faster and comprehensive diagnosis of brain tumorsCancer Institute Cancer Moonshot Scholars program to advance precision diagnosis of brain tumors in children.
Read more »
Study uncovers diversity of cancer-associated fibroblasts in skin cancerA study at MedUni Vienna's Department of Dermatology provides insights into the diversity of cancer-associated fibroblasts in white and black skin cancer and describes their different immunomodulatory roles in the tumor environment.
Read more »